News | September 07, 2008

Study Shows Cost Efficiency of Contrast Echocardiography to Triage ED Patients

September 8, 2008 - Excluding cardiac causes in patients presenting to the emergency department (ED) with chest pain using myocardial contrast echocardiography (MCE) can prevent unnecessary admissions, making it a cost-efficient tool in the evaluation of these patients, according to a study published in the Sept. 15 issue of the American Journal of Cardiology.

Assessment of patients presenting to the ED with suspected cardiac chest pain and a nondiagnostic electrocardiogram (ECG) is lengthy and costly and the study’s authors hypothesized MCE could be used as a more cost-efficient way to detecting those with chest pain that is noncardiac in nature. Accordingly, cost-efficiency was evaluated in 957 patients presenting to the ED with suspected cardiac chest pain, but no ST-segment elevation on the ECG, who underwent MCE. Economic outcome calculations were based on costs estimated from national average Medicare charges adjusted by a cost–charge ratio.

Based on routine clinical criteria, 641 patients (67 percent) were admitted to the hospital, whereas 316 (33 percent) were discharged directly from the ED. The average cost per patient using routine evaluation was $5,000. Patients with normal MCE results (523) had a very low primary event rate (death, acute myocardial infarction) of 0.6 percent within 24 hours after presentation, making it relatively safe to discharge patients directly from the ED with a normal MCE result. Researchers said if MCE had been used for decision making, 523 patients (55 percent) would have been discharged directly from the ED and 434 (45 percent) would have been admitted to the hospital, which would have prevented unnecessary admissions and tests and could have saved an average of $900 per patient.

The study was conducted by the Cardiovascular Division and Department of Emergency Medicine, Oregon Health and Science University, in Portland, OR. The work was supported by a grant from GE Healthcare and grants from the National Institutes of Health and the American Society of Echocardiography.

The study was conducted by doctors Jared J. Wyrick, Saul Kalvaitis, K. John McConnell, Diana Rinkevich, Sanjiv Kaul, and Kevin Wei.

For more information: www.ajconline.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init